• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

EVALUATING THE EFFECTIVENESS OF ANTIPLATELET THERAPY OF THE PATIENTS WITH KIDNEY DISEASE

    Nodir N. Sultonov, Maksud O. Sabirov, Mahsuma H. Tashpulatova, Lola I. Maksudova

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 1500-1505

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The study has evaluated the effectiveness of antiplatelet therapy of the patients with chronic kidney disease. The patients were divided into two groups when treating the disease, the first group was given allthrombosepin as antiplatelet therapy, and the second group was given dipyridamole. The research work was monitored for 10 days, during which the amount of urea in the blood was 9.6% compared to healthy people and a decrease in the amount of creatinine to 7.52%. Aggregation of thrombocytes was observed in the first group by 10.23% and 9.6% was in the second group. As can be seen from the results obtained, it has been proved that dipyridamole did not lag behind in effectiveness, which was taken from the factory as an antiplatelet therapy and was used with the locally developed allthrombosepin, as a traditional treatment, while treating chronic kidney disease (CKD).
Keywords:
  • PDF (257 K)
  • XML
(2020). EVALUATING THE EFFECTIVENESS OF ANTIPLATELET THERAPY OF THE PATIENTS WITH KIDNEY DISEASE. European Journal of Molecular & Clinical Medicine, 7(8), 1500-1505.
Nodir N. Sultonov, Maksud O. Sabirov, Mahsuma H. Tashpulatova, Lola I. Maksudova. "EVALUATING THE EFFECTIVENESS OF ANTIPLATELET THERAPY OF THE PATIENTS WITH KIDNEY DISEASE". European Journal of Molecular & Clinical Medicine, 7, 8, 2020, 1500-1505.
(2020). 'EVALUATING THE EFFECTIVENESS OF ANTIPLATELET THERAPY OF THE PATIENTS WITH KIDNEY DISEASE', European Journal of Molecular & Clinical Medicine, 7(8), pp. 1500-1505.
EVALUATING THE EFFECTIVENESS OF ANTIPLATELET THERAPY OF THE PATIENTS WITH KIDNEY DISEASE. European Journal of Molecular & Clinical Medicine, 2020; 7(8): 1500-1505.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 36
  • PDF Download: 74
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus